This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2006 Dec 7;355(23):2481-2.

doi: 10.1056/NEJMcibr065325.

Another look at imatinib mesylate

Klaus Strebhardt¹, Axel Ullrich

Affiliations

PMID: 17151370
DOI: 10.1056/NEJMcibr065325

Another look at imatinib mesylate

Klaus Strebhardt et al. N Engl J Med. 2006.

. 2006 Dec 7;355(23):2481-2.

doi: 10.1056/NEJMcibr065325.

Authors

Klaus Strebhardt¹, Axel Ullrich

Affiliation

¹ Department of Obstetrics and Gynecology, School of Medicine, J.W. Goethe University, Frankfurt, Germany.

PMID: 17151370
DOI: 10.1056/NEJMcibr065325

No abstract available

PubMed Disclaimer

Comment in

Another look at imatinib mesylate.
Schellings MW, Löwenberg B, Pinto YM. Schellings MW, et al. N Engl J Med. 2007 Mar 15;356(11):1183; author reply 1183. doi: 10.1056/NEJMc063721. N Engl J Med. 2007. PMID: 17361003 No abstract available.

Similar articles

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.
Kerkelä R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ, Rosenzweig A, Salomon RN, Van Etten RA, Alroy J, Durand JB, Force T. Kerkelä R, et al. Nat Med. 2006 Aug;12(8):908-16. doi: 10.1038/nm1446. Epub 2006 Jul 23. Nat Med. 2006. PMID: 16862153
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA, Junaid A, Siddiqui NS, Mukhtar K, Siddiqui S. Khan KA, et al. J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8. J Coll Physicians Surg Pak. 2008. PMID: 18460249
Imatinib mesylate induced skin hypopigmentation.
Talwar V, Doval DC, Bhatia K. Talwar V, et al. J Assoc Physicians India. 2007 Jul;55:527. J Assoc Physicians India. 2007. PMID: 17907508 No abstract available.
[Imatinib and solid tumours].
Arifi S, El Sayadi H, Dufresne A, Ray-Coquard I, Fayette J, Méeus P, Ranchère D, Decouvelaere AV, Alberti L, Tabone-Eglinger S, Blay JY, Cassier P. Arifi S, et al. Bull Cancer. 2008 Jan;95(1):99-106. doi: 10.1684/bdc.2008.0557. Bull Cancer. 2008. PMID: 18230575 Review. French.
[Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].
Usui N. Usui N. Rinsho Byori. 2004 Feb;52(2):136-44. Rinsho Byori. 2004. PMID: 15027317 Review. Japanese.

See all similar articles

Cited by

Chemotherapy and cardiotoxicity.
Broder H, Gottlieb RA, Lepor NE. Broder H, et al. Rev Cardiovasc Med. 2008 Spring;9(2):75-83. Rev Cardiovasc Med. 2008. PMID: 18660728 Free PMC article. Review.
The cancer cell's "power plants" as promising therapeutic targets: an overview.
Pedersen PL. Pedersen PL. J Bioenerg Biomembr. 2007 Feb;39(1):1-12. doi: 10.1007/s10863-007-9070-5. J Bioenerg Biomembr. 2007. PMID: 17404823 Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information